Working… Menu

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00907387
Recruitment Status : Completed
First Posted : May 22, 2009
Last Update Posted : January 17, 2014
Information provided by (Responsible Party):
Revance Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2009
Actual Study Completion Date : October 2009
Certification/Extension First Submitted : September 23, 2010